NDC 60505-2805-07 - Carbamazepine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-2805
- Requested NDC
- 60505-2805-07
- Package NDCs from labels
- 60505-2805-3, 60505-2805-7, 60505-2805-8, 60505-2805-07
- Manufacturer
- Apotex Corp. | Apotex Inc.
- Effective date
- 2026-09-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carbamazepine Extended-Release Capsules 100 mg, 200 mg and 300 mg Rx only | Apotex Corp. | Apotex Inc. | 2026-09-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Carbamazepine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-02-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Carbamazepine - AvPAK | AvPAK | 2026-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Carbamazepine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-10-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Carbamazepine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-10-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-2805-3 | Carbamazepine | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | 15 | |
| 60505-2805-7 | Carbamazepine | 120 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 120 | 15 | |
| 60505-2805-8 | Carbamazepine | 1000 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 1000 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-2805 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 14 | Current NDC, Legacy NDC, 3 package rows | 20240922_e91f9de3-3fdd-0a6b-71ce-53a2cc142816.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-2805-7 | EA - Each | 60505-2805 | a240e407-2f26-47eb-a74b-56925f8122d5 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CARBAMAZEPINE | ACTIVE INGREDIENT | 33CM23913M | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| CARBAMAZEPINE | ACTIVE MOIETY | 33CM23913M | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| ETHYLCELLULOSE (7 MPA.S) | INACTIVE INGREDIENT | H3UP11403C | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbamazepine | CARBAMAZEPINE | Apotex Corp. | e91f9de3-3fdd-0a6b-71ce-53a2cc142816 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | ANDA078986 60505-2805-7 60505-2807-3 60505-2807-5 60505-2807-7 60505-2806-7 60505-2805-8 60505-2806-3 60505-2806-8 60505-2805-3 60505-2807 60505-2805 60505-2806 60505280507 200131 388311 200133 c24e1663-4df1-d5a1-f9ed-551ba3552575 e91f9de3-3fdd-0a6b-71ce-53a2cc142816 33CM23913M |
| CARBAMAZEPINE | CARBAMAZEPINE | REMEDYREPACK INC. | 5f9535b1-ff6a-41b3-bbb2-efcf8fbacf4c | 2026-08-28 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| carbamazepine | CARBAMAZEPINE | Northstar Rx LLC | c91a5a1b-5481-445b-86e8-f10109ac3937 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| CARBAMAZEPINE | CARBAMAZEPINE | Apotex Corp. | bf0d012f-da14-8ce3-d74f-56172cddebc5 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| Carbamazepine | CARBAMAZEPINE | American Health Packaging | 87b87b57-021a-4cb2-9edd-6efa732c208f | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| Carbamazepine | CARBAMAZEPINE | Ascend Laboratories, LLC | f0a254c5-bd33-4b14-b9f0-830b3438f5c6 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| Tegretol | CARBAMAZEPINE | Novartis Pharmaceuticals Corporation | 8d409411-aa9f-4f3a-a52c-fbcb0c3ec053 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| Carbatrol | CARBAMAZEPINE | Takeda Pharmaceuticals America, Inc. | bc03e499-5bac-4293-bff4-6864153a624d | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | 200131 388311 200133 33CM23913M |
| Carbamazepine | CARBAMAZEPINE | Unichem Pharmaceuticals (USA), Inc. | 50ba2042-fc67-4266-a773-a30f07649a5a | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| Carbamazepine | CARBAMAZEPINE | Umedica Laboratories USA Inc. | 48080efd-1781-4585-83f8-c43957ac63b3 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| Carbamazepine | CARBAMAZEPINE | Umedica Laboratories USA Inc. | f3465f71-8931-43b6-baea-eac7046a4400 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| CARBAMAZEPINE | CARBAMAZEPINE | Alembic Pharmaceuticals Inc. | 87d343a8-84d5-4cdd-b0a0-629311b51f11 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| CARBAMAZEPINE | CARBAMAZEPINE | REMEDYREPACK INC. | 52cf3ba9-0a7c-4809-830e-af93d1532726 | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| carbamazepine | CARBAMAZEPINE | Zydus Lifesciences Limited | d10e5f83-56db-4bc9-8c51-150a2e3e20ea | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| carbamazepine | CARBAMAZEPINE | Zydus Pharmaceuticals (USA) Inc. | c5e4a25a-0137-4327-96f5-15735891ad5c | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| Carbamazepine | CARBAMAZEPINE | Torrent Pharmaceuticals Limited | 7c4860c1-daba-4e0f-97fd-d30cbc8603a2 | 2026-08-03 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| CARBAMAZEPINE | CARBAMAZEPINE | Torrent Pharmaceuticals Limited | 97e6e175-75e8-437b-b457-ddb1ae4e857d | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| Carbamazepine | CARBAMAZEPINE | REMEDYREPACK INC. | 9f3d91cd-a959-4e07-a51b-8a4e9ba9ece2 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| CARBAMAZEPINE | CARBAMAZEPINE | American Health Packaging | 7108d630-89bc-4815-b6fb-a1f4676c496e | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
| Carbamazepine | CARBAMAZEPINE | REMEDYREPACK INC. | 9471b7fb-29d3-4009-9d0f-f20c27351db5 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 33CM23913M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.